查看购物车
  • Traditional Chinese
  • English
  • Japanese
2021-2031年亚太地区颅脑植入物市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1843354

2021-2031年亚太地区颅脑植入物市场报告（范围、细分、动态和竞争分析）

Asia Pacific Cranial Implants Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 201 Pages | 订单完成后即时交付

价格

亚太地区颅骨植入物市场预计将大幅成长，到 2031 年将达到约 4.3654 亿美元，高于 2023 年的 2.484 亿美元，预测期内的年复合成长率(CAGR) 为 7.3%。

执行摘要和市场分析

亚太地区被公认为全球成长最快的颅脑植入物市场。该市场涵盖多个国家，包括中国、日本、印度、韩国、澳洲以及亚太地区的其他地区。中国、印度和日本是该市场扩张的主要动力，主要原因是老龄人口成长和神经系统疾病发生率上升。预计这些因素将在未来几年推动市场成长。此外，政府措施和非政府组织的宣传活动也进一步增强了市场活力。日本、中国和印度等国众多产业参与者的存在也对市场发展发挥至关重要的作用。

市场区隔分析

亚太地区颅骨植入物市场可根据类型、材料和应用进行细分：

  • 依类型：市场分为顶骨植入物、额骨植入物、枕骨植入物、颞骨植入物和蝶骨植入物。 2023年，顶骨植入物占据了最大的市场。
  • 依材质：细分包括聚甲基丙烯酸甲酯、聚醚醚酮、钛等，其中聚醚醚酮在 2023 年占据市场主导地位。
  • 按最终用户划分：市场分为医院、创伤中心和其他，其中医院在 2023 年占据最大份额。

市场展望

3D列印技术（又称增材製造）的出现正在彻底改变颅骨植入物的生产方式。该技术能够製造高度客製化、针对特定患者的植入物，与传统方案相比，其贴合度和功能性均更佳。能够精确复製个体颅骨几何形状，从而减少手术併发症并改善復健效果。此外，3D列印中多层技术的集成，使得能够生产具有不同特性的植入物，以满足特定功能需求，例如结构强度和生物相容性。这项创新改善了骨整合，最大限度地降低了植入物排斥的风险，并增强了对大脑的保护。

3D列印还能缩短生产时间，降低製造成本，并增强对复杂颅骨畸形的适应性。这些进步不仅改善了患者的治疗效果，也使颅骨植入物更容易被更广泛的患者群体所接受。因此，多层技术与3D列印的结合为颅骨植入物市场带来了巨大的成长机会。

国家洞察

亚太地区颅骨植入物市场主要涵盖中国、日本、印度、韩国、澳洲等国家，其中中国在2023年占最大市场份额。根据2023年发布的一项研究，中国报告指出2020年40岁以上人口的中风发生率为340万，盛行率为1780万。每年约有200万人首次经历中风，其中相当一部分人无法独立生活。颅骨植入物在中风治疗和復健的应用日益广泛，有助于术后保护和重建颅骨，同时可能有助于运动功能的恢復。

此外，中国创伤性脑损伤 (TBI) 发生率不断上升，估计每年新增病例约 772,800 至 892,800 例，这推动了颅脑植入物的需求。中国社会经济的快速发展、环境挑战、生活方式的改变以及城镇化进程为健康维护带来了挑战。政府的「健康中国2030」规划纲要强调了健康对经济成长的重要性，并大力投资医疗基础设施和技术，旨在提高医疗服务的可及性和品质。这些措施为颅脑植入物市场创造了有利的环境。

公司简介

亚太地区颅骨植入物市场的主要参与者包括史赛克公司 (Stryker Corp)、捷迈邦美控股公司 (Zimmer Biomet Holdings Inc)、Integra 生命科学控股公司 (Integra LifeSciences Holdings Corp)、OsteoMed SA、Anatomics Pty Ltd、Matrix Surgical Holdings LLC 等。这些公司正在采取各种策略，例如扩张、产品创新和併购，以提升其市场影响力，并为消费者提供创新解决方案。

目录

第一章：简介

第二章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：亚太地区颅骨植入物市场概况

  • 概述
  • PEST分析

第五章：亚太颅骨植入物市场－关键市场动态

  • 亚太颅骨植入物市场－关键市场动态
  • 市场驱动因素
    • 创伤性脑损伤盛行率上升
    • 老年人口激增
  • 市场限制
    • 植入物失败的风险
  • 市场机会
    • 融入原创多层技术的3D列印技术进步
  • 未来趋势
    • 客製化植入物
  • 驱动因素和限制因素的影响：

第六章：亚太地区颅骨植入物市场 - 分析

  • 2021-2031年亚太地区颅脑植入物市场收入
  • 亚太地区颅骨植入物市场预测分析

第七章：亚太地区颅骨植入物市场分析－依类型

  • 顶叶
  • 额叶
  • 枕骨
  • 颞
  • 蝶骨

第八章：亚太地区颅骨植入物市场分析－依材料

  • 聚甲基丙烯酸甲酯
  • 聚醚醚酮
  • 钛
  • 其他的

第九章：亚太地区颅骨植入物市场分析－依最终用户

  • 医院
  • 创伤中心
  • 其他的

第 10 章：亚太地区颅骨植入物市场 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 11 章：产业格局

  • 概述
  • 併购
  • 产品发布
  • 扩张和其他策略发展

第十二章：公司简介

  • Stryker Corp
  • Zimmer Biomet Holdings Inc
  • Integra LifeSciences Holdings Corp
  • OsteoMed SA
  • Anatomics Pty Ltd
  • Matrix Surgical Holdings LLC
  • Calavera Surgical
  • Medtronic Plc
  • Xilloc Medical BV
  • Johnson & Johnson
  • evonos GmbH & Co. KG
  • B Braun SE
  • UAB Ortho Baltic
  • 3D Systems Corp
  • GPC Medical Ltd
  • Bioplate Inc
  • EUROS SAS
  • Biocomposites Ltd
  • Medprin Biotech GmbH
  • Kelyniam Global Inc
  • MedCAD
  • KLS Martin Group
  • Longeviti Neuro Solutions LLC

第 13 章：附录

Product Code: BMIRE00031982

The Asia Pacific cranial implants market is projected to grow significantly, reaching approximately US$ 436.54 million by 2031, up from US$ 248.40 million in 2023, with a compound annual growth rate (CAGR) of 7.3% during the forecast period.

Executive Summary and Market Analysis

The Asia Pacific region is recognized as the fastest-growing market for cranial implants globally. This market encompasses several countries, including China, Japan, India, South Korea, Australia, and other regions within Asia Pacific. Key contributors to the market's expansion include China, India, and Japan, driven by an increasing elderly population and a rise in neurological disorders. These factors are expected to propel market growth in the coming years. Additionally, government initiatives and awareness campaigns by non-governmental organizations are further enhancing market dynamics. The presence of numerous industry players in countries like Japan, China, and India also plays a crucial role in the market's development.

Market Segmentation Analysis

The Asia Pacific cranial implants market can be segmented based on type, material, and application:

  • By Type: The market is divided into parietal, frontal, occipital, temporal, and sphenoid implants. In 2023, parietal implants held the largest market share.
  • By Material: The segmentation includes polymethyl methacrylate, polyether ether ketone, titanium, and others, with polyether ether ketone leading the market in 2023.
  • By End User: The market is categorized into hospitals, trauma centers, and others, where hospitals accounted for the largest share in 2023.

Market Outlook

The advent of 3D printing technology, also known as additive manufacturing, is revolutionizing the production of cranial implants. This technology allows for the creation of highly customized, patient-specific implants that offer better fit and functionality compared to traditional options. The ability to replicate an individual's skull geometry precisely reduces surgical complications and enhances recovery outcomes. Furthermore, the integration of multilayer technology in 3D printing enables the production of implants with varying properties tailored for specific functions, such as structural strength and biocompatibility. This innovation improves osseointegration, minimizes the risk of implant rejection, and provides enhanced protection for the brain.

3D printing also facilitates faster production times, lowers manufacturing costs, and offers greater adaptability to complex cranial deformities. These advancements not only enhance patient outcomes but also make cranial implants more accessible to a wider patient demographic. Consequently, the integration of multilayer technology in 3D printing presents significant opportunities for growth in the cranial implant market.

Country Insights

The Asia Pacific cranial implants market includes key countries such as China, Japan, India, South Korea, Australia, and others, with China holding the largest market share in 2023. According to a study published in 2023, China reported a stroke incidence of 3.4 million and a prevalence of 17.8 million among individuals aged 40 and above in 2020. Each year, around 2 million people experience their first stroke, with a significant percentage unable to live independently. Cranial implants are increasingly utilized in stroke treatment and rehabilitation, serving to protect and reconstruct the skull post-surgery while potentially aiding in motor function recovery.

Moreover, the rising incidence of traumatic brain injuries (TBIs) in China, estimated at approximately 772,800 to 892,800 new cases annually, is driving demand for cranial implants. The rapid socioeconomic development, environmental challenges, lifestyle changes, and urbanization in China pose health maintenance obstacles. The government's Healthy China 2030 Plan highlights the importance of health for economic growth, with substantial investments in healthcare infrastructure and technology aimed at improving access and quality. These initiatives create a favorable environment for the cranial implants market.

Company Profiles

Key players in the Asia Pacific cranial implants market include Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, and others. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Cranial Implants Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Asia Pacific Cranial Implants Market - Key Market Dynamics

  • 5.1 Asia Pacific Cranial Implants Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increase in Prevalence of Traumatic Brain Injuries
    • 5.2.2 Surge in Elderly Populations
  • 5.3 Market Restraints
    • 5.3.1 Risk of Implant Failure
  • 5.4 Market Opportunities
    • 5.4.1 Advancements in 3D Printing with Incorporation of Original Multilayer Technology
  • 5.5 Future Trends
    • 5.5.1 Customized Implants
  • 5.6 Impact of Drivers and Restraints:

6. Asia Pacific Cranial Implants Market - Analysis

  • 6.1 Asia Pacific Cranial Implants Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Cranial Implants Market Forecast Analysis

7. Asia Pacific Cranial Implants Market Analysis - by Type

  • 7.1 Parietal
    • 7.1.1 Overview
    • 7.1.2 Parietal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Frontal
    • 7.2.1 Overview
    • 7.2.2 Frontal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Occipital
    • 7.3.1 Overview
    • 7.3.2 Occipital: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Temporal
    • 7.4.1 Overview
    • 7.4.2 Temporal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Sphenoid
    • 7.5.1 Overview
    • 7.5.2 Sphenoid: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Cranial Implants Market Analysis - by Material

  • 8.1 Polymethyl Methacrylate
    • 8.1.1 Overview
    • 8.1.2 Polymethyl Methacrylate: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Polyether Ether Ketone
    • 8.2.1 Overview
    • 8.2.2 Polyether Ether Ketone: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Titanium
    • 8.3.1 Overview
    • 8.3.2 Titanium: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Cranial Implants Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Trauma Centers
    • 9.2.1 Overview
    • 9.2.2 Trauma Centers: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Cranial Implants Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Cranial Implants Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Asia Pacific Cranial Implants Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 China: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.2.2 China: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.2.3 China: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.3 Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Japan: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.3.2 Japan: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.3.3 Japan: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.4 India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 India: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.4.2 India: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.4.3 India: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.5 Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Australia: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.5.2 Australia: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.5.3 Australia: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.6 South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 South Korea: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.6.2 South Korea: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.6.3 South Korea: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.7 Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of APAC: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.7.2 Rest of APAC: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.7.3 Rest of APAC: Asia Pacific Cranial Implants Market Share - by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Mergers and Acquisitions
  • 11.3 Product Launch
  • 11.4 Expansions and Other Strategic Developments

12. Company Profiles

  • 12.1 Stryker Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Zimmer Biomet Holdings Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Integra LifeSciences Holdings Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 OsteoMed SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Anatomics Pty Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Matrix Surgical Holdings LLC
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Calavera Surgical
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Xilloc Medical BV
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Johnson & Johnson
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 evonos GmbH & Co. KG
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 B Braun SE
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 UAB Ortho Baltic
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 3D Systems Corp
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 GPC Medical Ltd
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 Bioplate Inc
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 EUROS SAS
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments
  • 12.18 Biocomposites Ltd
    • 12.18.1 Key Facts
    • 12.18.2 Business Description
    • 12.18.3 Products and Services
    • 12.18.4 Financial Overview
    • 12.18.5 SWOT Analysis
    • 12.18.6 Key Developments
  • 12.19 Medprin Biotech GmbH
    • 12.19.1 Key Facts
    • 12.19.2 Business Description
    • 12.19.3 Products and Services
    • 12.19.4 Financial Overview
    • 12.19.5 SWOT Analysis
    • 12.19.6 Key Developments
  • 12.20 Kelyniam Global Inc
    • 12.20.1 Key Facts
    • 12.20.2 Business Description
    • 12.20.3 Products and Services
    • 12.20.4 Financial Overview
    • 12.20.5 SWOT Analysis
    • 12.20.6 Key Developments
  • 12.21 MedCAD
    • 12.21.1 Key Facts
    • 12.21.2 Business Description
    • 12.21.3 Products and Services
    • 12.21.4 Financial Overview
    • 12.21.5 SWOT Analysis
    • 12.21.6 Key Developments
  • 12.22 KLS Martin Group
    • 12.22.1 Key Facts
    • 12.22.2 Business Description
    • 12.22.3 Products and Services
    • 12.22.4 Financial Overview
    • 12.22.5 SWOT Analysis
    • 12.22.6 Key Developments
  • 12.23 Longeviti Neuro Solutions LLC
    • 12.23.1 Key Facts
    • 12.23.2 Business Description
    • 12.23.3 Products and Services
    • 12.23.4 Financial Overview
    • 12.23.5 SWOT Analysis
    • 12.23.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 List of Abbreviations

List Of Tables

  • Table 1. Asia Pacific Cranial Implants Market Segmentation
  • Table 2. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Material
  • Table 5. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 9. China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 10. Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 12. Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 13. India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 15. India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 16. Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 18. Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 19. South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 20. South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 21. South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 22. Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 23. Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 24. Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 25. List of Abbreviations

List Of Figures

  • Figure 1. Asia Pacific Cranial Implants Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Cranial Implants Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Cranial Implants Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Parietal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Frontal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Occipital: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Temporal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Sphenoid: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Asia Pacific Cranial Implants Market Share (%) - by Material (2023 and 2031)
  • Figure 12. Polymethyl Methacrylate: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Polyether Ether Ketone: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Titanium: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Asia Pacific Cranial Implants Market Share (%) - by End User (2023 and 2031)
  • Figure 17. Hospitals: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Trauma Centers: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Asia Pacific Cranial Implants Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)